Technology News and Research

RSS

OS data from ImmunoGen's trastuzumab emtansine Phase III trial on breast cancer

ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.

2 Oct 2012

Roundup: Calif. bans gay 'cure' for minors; Pittsburgh health system merger falls apart; Ariz. seeks federal approval to continue Medicaid program

California has become the first state to ban the use for minors of disputed therapies to "overcome" homosexuality, a step hailed by gay rights groups across the country that say the therapies have caused dangerous emotional harm to gay and lesbian teenagers.

2 Oct 2012

Rotator cuff anchor launched by DePuy Mitek

...

2 Oct 2012

Thermal imaging camera monitors pain processing in patients suffering from small fiber neuropathy

Early results from the NeuroSIPE* programme 'Beyond Pain' project, in research funded by the Dutch Technology Foundation STW, demonstrate how a FLIR SC5600 thermal imaging camera has been used as an effective, non-invasive tool for monitoring of pain processing in the central nervous system of patients suffering from small fiber neuropathy.

2 Oct 2012

Five prominent surgeons receive Honorary Fellowship from ACS

Last night Honorary Fellowship in the American College of Surgeons (ACS) was awarded to five prominent surgeons from Japan, the Philippines, Mexico, England, and Belgium during Convocation ceremonies that preceded the official opening of the 2012 ACS Annual Clinical Congress.

1 Oct 2012

Common RNA pathway links frontotemporal lobar dementia with ALS

Two proteins previously found to contribute to ALS, also known as Lou Gehrig's disease, have divergent roles. But a new study, led by researchers at the Department of Cellular and Molecular Medicine at the University of California, San Diego School of Medicine, shows that a common pathway links them.

1 Oct 2012

Precyse releases new report on ICD-10

Precyse, a leader in health information management (HIM) technologies and services, leading up to the 2012 American Health Information Management Association (AHIMA) Convention and Exhibit, released a new report titled, "Breaking the Code: The Impact of ICD-10 on Documentation and CDI Drives the Need for Organization-Wide Education."

1 Oct 2012

Rehabilitation robots help identify and customize post-stroke therapy

When it comes to stroke rehabilitation, it takes a dedicated team to help a person regain as much independence as possible: physicians, nurses, physiotherapists, occupational therapists, speech-language pathologists, recreation therapists, caregivers and others. Now, a University of Calgary research team has added a robot to help identify and customize post-stroke therapy.

1 Oct 2012

Bioengineers design inexpensive, rapid medical diagnostic tests

By mimicking nature's own sensing mechanisms, bioengineers at UC Santa Barbara and University of Rome Tor Vergata have designed inexpensive medical diagnostic tests that take only a few minutes to perform.

29 Sep 2012

Patients, physicians face health IT divide

When it comes to consumer use of health information technology, demand seems to be outstripping supply and it's creating a great healthcare chasm. Results of a new survey show that, while three out of four patients are eager to access health records online through EMRs and more than 60 percent want to communicate with their doctor via email or other Internet technology, only 40 percent of physicians said they had the capability to interact with patients through email or give them access to their online health records.

29 Sep 2012

PLOS ONE journal releases report on validation of Falcon Genomics' Cancer BioChip System

The online journal PLOS ONE released a scientific report on the validation of Falcon Genomics' Cancer BioChip System (CBCS) as a tool for identifying inhibitors of breast cancer.

29 Sep 2012

Cardiac Dimensions commences commercialization of CARILLON mitral contour system in Europe

Cardiac Dimensions, Inc. today announced that it has initiated its commercial efforts in Europe, treating the first patients with its CARILLON Mitral Contour System under its Conformite Europeenne (CE) Mark approval.

29 Sep 2012

MicroDose completes third and final MDT-637 Phase 1 study on RSV infection

MicroDose Therapeutx, Inc., announced today the completion of its third and final Phase 1 clinical study for MDT-637 with its novel inhaled antiviral fusion inhibitor, MDT-637, for the treatment of RSV infection.

29 Sep 2012

UBM Live announces finalists of CPhI Pharma Awards

Leading events organiser, UBM Live, announced the finalists of the CPhI Pharma Awards. Formerly known as the Innovation Awards, the rebranded CPhI Pharma Awards feature a gold, silver and bronze winner for the returning Best Pharma Innovation award.

29 Sep 2012

Collaborative Spine completes research agenda-setting process for spine care

The Collaborative Spine Research Foundation (Collaborative Spine) today announced it has completed the process of setting a research agenda for spine care. The agenda articulates the most critical clinical research issues that need to be addressed in order to deliver on the Foundation's commitment to advance the science and practice of the highest-quality spine care.

29 Sep 2012

FDA approves Globus Medical’s SECURE-C Cervical Artificial Disc

Globus Medical, Inc., today announced that the Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the SECURE-C Cervical Artificial Disc. Clinical data from a 380 patient investigational device exemption (IDE) study demonstrate that SECURE-C is statistically superior to anterior cervical discectomy and fusion (ACDF) in terms of overall success, subsequent surgery at the index level, device-related adverse events, and patient satisfaction at 24 months.

29 Sep 2012

Autism Speaks announces new round of research grants

Autism Speaks, the world's leading autism science and advocacy organization, today announced the awarding of new research grants totaling nearly $5 million. "Autism Speaks is committed to continuing our research which has tremendous potential to increase our understanding of autism and addressing the needs of individuals with autism," said Autism Speaks Co-founder Bob Wright, "and we are grateful to the donors who make this research possible."

29 Sep 2012

BioTime forms new wholly owned subsidiary

BioTime, Inc., an Alameda-based company engaged in research and development of innovative new products in the field of regenerative medicine utilizing stem cells and related technology, announced today that it has formed a new wholly owned subsidiary, BioTime Acquisition Corporation, to pursue opportunities and acquire assets and businesses in the fields of stem cells and regenerative medicine.

29 Sep 2012

The Genealogy Event to discuss scientific breakthroughs in human genomic study

Scientific breakthroughs in the study of the human genome coupled with online access to massive genealogical records have opened the doors of ancestral investigation to include all those interested in unearthing their roots and, on October 26-27 at the Metropolitan Pavilion in New York City, The Genealogy Event will feature exciting learning opportunities and resources for both novice and professional enthusiasts.

28 Sep 2012

The state of science and technology in Canada, 2012

An authoritative, evidence-based assessment of the state of science and technology in Canada has found that Canadian science and technology is healthy, growing and internationally respected. Over the past five years, real improvements have occurred in the magnitude and quality of Canadian science and technology.

28 Sep 2012